Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huixun Jia

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Value of Predictive Markers in Immune OncologyZhenyu Wu, Huixun Jia
Lancet (London, England)|March 8, 2025
Gene therapy for AMD: better as an adjuvant than a replacementHuixun Jia, Xiaodong Sun
JAMA Ophthalmology|February 27, 2025
Slowing Geographic Atrophy-Hopeful Progress or Uncertain BenefitHuixun Jia, Xiaodong Sun
Lancet (London, England)|January 23, 2018
GRECCAR2 trial: details worthy of more attentionHuixun Jia, Yun Guan, Ji Zhu
The Lancet. Oncology|August 14, 2018
Sex as a predictor of response to cancer immunotherapyTao Zhang, Huixun Jia, Zhenyu Wu
Retina (Philadelphia, Pa.)|January 25, 2023
THE REPORTING QUALITY OF NONINFERIORITY TRIALS USING INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORSHuixun Jia, Tong Li, Hongli Wan, et al.
The Oncologist|January 17, 2020
Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based AnalysisHuixun Jia, Qingguo Li, Jing Yuan, et al.
BMC Cancer|July 27, 2017
Assessing the adequacy of lymph node yield for different tumor stages of colon cancer by nodal staging scoresZhenyu Wu, Guoyou Qin, Naiqing Zhao, et al.
Pharmacological Research|August 15, 2024
Comprehensive assessment of the impact of intravitreal faricimab on retinal diseases: A systematic review, meta-analysis, and trial sequential analysisGuanran Zhang, Xin Wen, Yanrong Li, et al.
Aging|October 13, 2020
Risk factors and prediction of second primary cancer in primary female non-metastatic breast cancer survivorsXiwen Qian, Huixun Jia, Yue Zhang, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Value of Predictive Markers in Immune OncologyZhenyu Wu, Huixun Jia
Lancet (London, England)|March 8, 2025
Gene therapy for AMD: better as an adjuvant than a replacementHuixun Jia, Xiaodong Sun
JAMA Ophthalmology|February 27, 2025
Slowing Geographic Atrophy-Hopeful Progress or Uncertain BenefitHuixun Jia, Xiaodong Sun
Lancet (London, England)|January 23, 2018
GRECCAR2 trial: details worthy of more attentionHuixun Jia, Yun Guan, Ji Zhu
The Lancet. Oncology|August 14, 2018
Sex as a predictor of response to cancer immunotherapyTao Zhang, Huixun Jia, Zhenyu Wu
Retina (Philadelphia, Pa.)|January 25, 2023
THE REPORTING QUALITY OF NONINFERIORITY TRIALS USING INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORSHuixun Jia, Tong Li, Hongli Wan, et al.
The Oncologist|January 17, 2020
Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based AnalysisHuixun Jia, Qingguo Li, Jing Yuan, et al.
BMC Cancer|July 27, 2017
Assessing the adequacy of lymph node yield for different tumor stages of colon cancer by nodal staging scoresZhenyu Wu, Guoyou Qin, Naiqing Zhao, et al.
Pharmacological Research|August 15, 2024
Comprehensive assessment of the impact of intravitreal faricimab on retinal diseases: A systematic review, meta-analysis, and trial sequential analysisGuanran Zhang, Xin Wen, Yanrong Li, et al.
Aging|October 13, 2020
Risk factors and prediction of second primary cancer in primary female non-metastatic breast cancer survivorsXiwen Qian, Huixun Jia, Yue Zhang, et al.
Pageof 10